Blue Wolf Capital Acquires European Pharma Facilities from Recipharm
Slice of Healthcare Team
Sep 30, 2024
Key Highlights
- Blue Wolf Capital acquires seven European facilities from Recipharm, specializing in oral solid, semi-solid, and liquid dosage pharmaceutical products.
- The acquisition supports Blue Wolf’s goal to build an industry-leading CDMO platform.
- Blue Wolf also plans to acquire Synerlab, a CDMO in France and Spain, pending regulatory approval.
- Bruce Vielle will serve as CEO of the combined organization, supported by a team of industry experts.
Source: Business Wire
Notable Quotes
“ By honoring both cultures, we will create an even stronger and more exciting one to serve our customers and patients. ”
Bruce Vielle, Chief Executive Officer at Synerlab
“ We see significant growth potential in these facilities and look forward to building a best-in-class CDMO focused on delivering outstanding service and high-quality pharmaceutical products. ”
Shashank Patel, Principal at Blue Wolf
